SNAC for Enhanced Oral Bioavailability: An Updated Review

Pharm Res. 2023 Mar;40(3):633-650. doi: 10.1007/s11095-022-03459-9. Epub 2022 Dec 20.

Abstract

The delivery of proteins and peptides via an oral route poses numerous challenges to improve the oral bioavailability and patient compliance. To overcome these challenges, as well as to improve the permeation of proteins and peptides via intestinal mucosa, several chemicals have been studied such as surfactants, fatty acids, bile salts, pH modifiers, and chelating agents, amongst these medium chain fatty acid like C10 (sodium caprate) and Sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) and its derivatives that have been well studied from a clinical perspective. This current review enumerates the challenges involved in protein and peptide delivery via the oral route, i.e., non-invasive routes of protein and peptide administration. This review also covers the chemistry behind SNAC and toxicity as well as mechanisms to enhance the oral delivery of clinically proven molecules like simaglutide and other small molecules under clinical development, as well as other permeation enhancers for efficient delivery of proteins and peptides.

Keywords: SNAC; oral bioavailability; permeation enhancement; protein and peptide delivery.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Fatty Acids* / metabolism
  • Humans
  • Intestinal Absorption
  • Intestinal Mucosa* / metabolism
  • Pharmaceutical Preparations / metabolism
  • Proteins / metabolism

Substances

  • Pharmaceutical Preparations
  • Fatty Acids
  • Proteins